Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
All articles by Andrea S. Blevins Primeau, PhD, MBA
Surgical Resection Improves Long-Term Outcomes in T1 Colorectal Cancer
Surgical resection generally improves long-term outcomes over local resection in high-risk, T1 colorectal cancer, a study suggests.
Patterns of COVID-19 Vaccination in Cancer Patients Who Already Had COVID-19
Several factors influenced the likelihood of COVID-19 vaccination among patients with cancer who already had COVID-19, a new study suggests.
Vistusertib Provides No Benefit in Platinum-Resistant/Refractory Ovarian Cancer
Adding vistusertib to treatment with paclitaxel does not improve outcomes in patients with platinum-resistant or -refractory ovarian cancer, a phase 2 trial suggests.
Robust Breast Cancer Patients Have Higher Risk of Worsening Frailty Status
Non-frail patients with early-stage breast cancer have an increased risk of worsening frailty status after locoregional therapy, a study suggests.
Aspirin and Metformin Combo Linked to Higher Risk of Cancer Death
Among older patients with diabetes, metformin was associated with a reduced risk of cancer, but the combination of aspirin and metformin was associated with an increased risk of cancer death.
Personalized ctDNA Monitoring Can Predict Outcomes in Advanced Melanoma
Personalized ctDNA monitoring can predict outcomes during and after treatment in patients with advanced melanoma, a study suggests.
Alisertib Does Not Restore Sensitivity to Fulvestrant in Endocrine-Resistant Breast Cancer
Alisertib monotherapy has shown activity in postmenopausal patients with endocrine-resistant, HER2-negative, metastatic breast cancer, but it was not able to restore sensitivity to fulvestrant in this patient population.
Certain Antibiotics May Reduce the Efficacy of Certain ICIs in Cancer Patients
A new study suggests that fluoroquinolones — but not other antibiotics — may reduce the efficacy of certain ICIs in certain cancers.
COVID-19 Sequelae in Cancer by Vaccination Status and Variant Era
COVID-19 vaccination may reduce the risk of COVID-19 sequelae in patients with cancer, according to researchers.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...